Recently introduced qacA/B genes in Staphylococcus epidermidis do not increase chlorhexidine MIC/MBC

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 10, 2013, Pages 2226-2233

  Skovgaard, Sissel ^a,b   Larsen, Marianne Halberg ^a   Nielsen, Lene Nørby ^a   Skov, Robert Leo ^c   Wong, Christian ^b   Westh, Henrik ^a,b   Ingmer, Hanne ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Antimicrobial resistance; Biocide susceptibility; Hand rubs; Hospital disinfection; Infection control

Indexed keywords

BACTERIAL PROTEIN; BIOCIDE; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; IDUSCRUB; QACA PROTEIN; QACB PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISINFECTION; DRUG MARKETING; GENE; GENETIC ANALYSIS; HAND WASHING; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTIOUS ARTHRITIS; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION;

ANTIMICROBIAL RESISTANCE; BIOCIDE SUSCEPTIBILITY; HAND RUBS; HOSPITAL DISINFECTION; INFECTION CONTROL;

BACTERIAL PROTEINS; CHLORHEXIDINE; DISINFECTANTS; DRUG TOLERANCE; GENE TRANSFER, HORIZONTAL; HAND DISINFECTION; HUMANS; INFECTION CONTROL; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; NURSES; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84887822370     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt182     Document Type: Article

References (33)

1. WHO. WHO Guidelines on Hand Hygiene in Health Care. 2009. http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf (21 February 2013, date last accessed).
2. Nielsen L, Pagh M, Strøbæk S et al. Ra°d og anvisninger om desinfektion i sundhedssektoren. Copenhagen: Statens Serum Institut, 2004.
3. Davies GE, Francis J, MartinARetal.1:6-Di-4'-chlorophenyldiguanidohexane (hibitane). Laboratory investigation of a new antibacterial agent of high potency. Br J Pharmacol Chemother 1954; 9: 192-6.
4. National Board of Health SST. Prevention of MRSA Spreading, Guidelines. 2008. http://www.sst.dk/publ/publ2008/CFF/MRSA/MRSA_vejl_en_19mar 08.pdf (21 February 2013, date last accessed).
5. National Board of Health SST. Vejledning om forebyggelse af spredning af MRSA. 2012. http://www.sst.dk/publ/Publ2012/11nov/MRSAvejl2udg.pdf (21 February 2013, date last accessed).
6. Lowbury EJ. Skin disinfection. J Clin Pathol 1961; 14: 85-90.
7. Lowbury EJ, Lilly HA. Use of 4 per cent chlorhexidine detergent solution (Hibiscrub) and other methods of skin disinfection. Br Med J 1973; 1: 510-5.
8. SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). Assessment of the Antibiotic Resistance Effects of Biocides. 2009. http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_ o_021.pdf (21 February 2013, date last accessed).
9. Horner C, Mawer D, Wilcox M. Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? J Antimicrob Chemother 2012; 67: 2547-59.
10. Batra R, Cooper BS, Whiteley C et al. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010; 50: 210-7.
11. Lee AS, Macedo-Vinas M, Francois P et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011; 52: 1422-30.
12. Zhang M, O'Donoghue MM, Ito T et al. Prevalence of antiseptic-resistance genes in Staphylococcus aureus and coagulasenegative staphylococci colonising nurses and the general population in Hong Kong. J Hosp Infect 2011; 78: 113-7.
13. Sidhu MS, Heir E, Leegaard T et al. Frequency of disinfectant resistance genes and genetic linkage with b-lactamase transposon Tn552 among clinical staphylococci. Antimicrob Agents Chemother 2002; 46: 2797-803.
14. Kloos WE, Musselwhite MS. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol 1975; 30: 381-5.
15. Wisplinghoff H, Bischoff T, Tallent SM et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
16. Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am 2009; 23: 73-98.
17. Otto M. Staphylococcus epidermidis-the "accidental" pathogen. Nat Rev Microbiol 2009; 7: 555-67.
18. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-54.
19. Mayer S, Boos M, Beyer A et al. Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. J Antimicrob Chemother 2001; 47: 896-7.
20. Smith K, Gemmell CG, Hunter IS. The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates. J Antimicrob Chemother 2008; 61: 78-84.
21. Poole K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 2005; 56: 20-51.
22. Noguchi N, Nakaminami H, Nishijima S et al. Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome. J Clin Microbiol 2006; 44: 2119-25.
23. EUCAST. Antimicrobial Susceptibility Testing EUCAST Disk Diffusion Method. 2012. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_ files/Disk_test_documents/Manual_v_2.1_EUCAST_Disk_Test.pdf (21 February 2013, date last accessed).
24. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters. 2012. http://www.eucast.org/fileadmin/src/media/PDFs/EUCA ST_files/Breakpoint_tables/Breakpoint_table_v_2.0_120221.pdf (21 February 2013, date last accessed).
25. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.
26. Multilocus Sequence Typing. http://sepidermidis.mlst.net/ (21 February 2013, date last accessed).
27. Tennent JM, Lyon BR, Gillespie MT et al. Cloning and expression of Staphylococcus aureus plasmid-mediated quaternary ammonium resistance in Escherichiacoli. Antimicrob Agents Chemother 1985; 27: 79-83.
28. Paulsen IT, Brown MH, Skurray RA. Characterization of the earliest known Staphylococcus aureus plasmid encoding a multidrug efflux system. J Bacteriol 1998; 180: 3477-9.
29. Faul F, Erdfelder E, Lang AG et al. G*Power 3: a flexible statistical power analysis programfor the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-91.
30. Cookson BD, Bolton MC, Platt JH. Chlorhexidine resistance in methicillin-resistant Staphylococcus aureus or just an elevated MIC? An in vitro and in vivo assessment. Antimicrob Agents Chemother 1991; 35: 1997-2002.
31. Sheng WH, Wang JT, Lauderdale TL et al. Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility. Diagn Microbiol Infect Dis 2009; 63: 309-13.
32. Leelaporn A, Paulsen IT, Tennent JM et al. Multidrug resistance to antiseptics and disinfectants in coagulase-negative staphylococci. J Med Microbiol 1994; 40: 214-20.
33. Skovgaard S, Nielsen LN, Larsen MH et al. Staphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates. PLoS ONE 2013; 8: e62197. doi:10.1371/journal.pone0062197.